171 related articles for article (PubMed ID: 33843880)
1. Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress.
Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 14(9):1-24. PubMed ID: 33843880
[No Abstract] [Full Text] [Related]
2. Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: commentary.
Garcia-Manero G
Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 14(9):20-23. PubMed ID: 33843881
[No Abstract] [Full Text] [Related]
3. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):1-24. PubMed ID: 33843919
[No Abstract] [Full Text] [Related]
4. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting: commentary.
Garcia-Manero G
Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):18-22. PubMed ID: 33843920
[No Abstract] [Full Text] [Related]
5. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):1-24. PubMed ID: 33843865
[No Abstract] [Full Text] [Related]
6. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Garcia-Manero G
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
[No Abstract] [Full Text] [Related]
7. Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting.
Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 5(2):1-19. PubMed ID: 31730586
[No Abstract] [Full Text] [Related]
8. Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting: Commentary.
Garcia-Manero G
Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 5(2):16-19. PubMed ID: 31730587
[No Abstract] [Full Text] [Related]
9. Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report.
Abdallah M; Akhtar OS; Major A; Mian H; Tsang M; Torka P
J Geriatr Oncol; 2024 Jun; 15(5):101762. PubMed ID: 38609752
[No Abstract] [Full Text] [Related]
10. A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.
Cheson BD; Ashforth E
Clin Adv Hematol Oncol; 2009 Sep; 7(9 Suppl 15):1-22; quiz 23-4. PubMed ID: 20102012
[No Abstract] [Full Text] [Related]
11. [Munich Hematology Congress. 26th annual meeting of the German Society for Hematology and Oncology, 11-14 October 1981. Abstracts].
Onkologie; 1981 Oct; 4(5):239-87. PubMed ID: 6117044
[No Abstract] [Full Text] [Related]
12. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
13. Speaking a common language in MDS/MPNs.
Steensma DP
Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Treatment of MDS. A review of selected presentations from the 48th Annual Meeting of the American Society of Hematology, December 9-12, 2006, Orlando, Florida.
Garcia-Manero G
Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 6):1-13; quiz 15-6. PubMed ID: 17519888
[No Abstract] [Full Text] [Related]
15. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
[No Abstract] [Full Text] [Related]
16. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Davids MS
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
[No Abstract] [Full Text] [Related]
17. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):1-24. PubMed ID: 33843909
[No Abstract] [Full Text] [Related]
18. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
[No Abstract] [Full Text] [Related]
19. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary.
Straus DJ
Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):20-23. PubMed ID: 33843910
[No Abstract] [Full Text] [Related]
20. Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 7(2):1-24. PubMed ID: 33843871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
